<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "basiliximab inj VIAL">
<dose><value>20</value>
<value>10</value>
<value>12</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>basiliximab inj VIAL</value>
</drugname><strength><value>20 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer within 2 hours pre-transplant in operating room (day zero)</value>
<value>Administer 1 dose on day 4 post-transplant.</value>
<value>Administer 1 dose on day 4 post-transplant. Hold dose if complications occur.</value>
<value>INITIAL DOSE: Administer within 6 hours of organ perfusion.</value>
<value>SECOND DOSE: Administer 1 dose on Day 4 post-transplant. Hold dose if complications occur.</value>
<value>THIRD DOSE: Administer 1 dose between Day 8 and Day 10 post-transplant IF ascites fluid loss exceeds 70 mL/kg or is more than 5 L.</value>
<value>Administer immediately prior to cardiopulmonary bypass started or within 6 hours of organ perfursion.</value>
<value>Administer within 2 hours pre-transplant in operating room (day zero). MAXIMUM dose = 20 mg.</value>
<value>Administer 1 dose on day 4 post-transplant. MAXIMUM dose = 20 mg.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
<value>mg/m2</value>
</units><additionalnotes><value></value>
<value>Renal Transplant - Infants/Children &amp;lt; 35 kg</value>
<value>Renal Transplant - Infants/Children &amp;gt; 35 kg</value>
<value>Liver Transplant - Infants/Children &amp;lt;35 kg.</value>
<value>Liver Transplant - Infants/Children &amp;gt;35 kg.</value>
<value>Heart Transplant - Infants/Children &amp;lt; 35 kg</value>
<value>Heart Transplant - Infants/Children &amp;gt; 35 kg</value>
<value>Children: 2 to 15 years of age</value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>Specialized High Cost Drug List</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Immunosuppressive Agents</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>